2-Cyano-N-(ethylcarbamoyl)acetamide CAS:41078-06-2

2-Cyano-N-(ethylcarbamoyl)acetamide

Chemical Name:2-Cyano-N-(ethylcarbamoyl)acetamide
CAS.NO:41078-06-2
Synonyms:2-Cyano-N-(ethylcarbamoyl)acetamide
1-(2-cyanoacetyl)-3-ethylurea
N-ethyl-N'-cyanoacetyl-urea
N-Aethyl-N'-cyanacetyl-harnstoff
N-Aethyl-N'-cyanoacetylharnstoff
 
Physical and Chemical Properties:
Density 1.168g/cm3
Molecular Formula C6H9N3O2
Molecular Weight 155.15500
Index of Refraction 1.469
 
Specification:
Appearance:Off-white powder
Assay:≥98.0%
Moisture:≤0.5%
pH:5-7
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Cymoxanil(CAS:57966-95-7).



We are professional 2-Cyano-N-(ethylcarbamoyl)acetamide manufacturer and N-Aethyl-N’-cyanoacetylharnstoff supplier in China, We offer quality 2-Cyano-N-(ethylcarbamoyl)acetamide you can fully trust, also we have India factory and producer of N-Aethyl-N’-cyanoacetylharnstoff,Pls send inquiry of 2-Cyano-N-(ethylcarbamoyl)acetamide CAS:41078-06-2 to info@nbinno.com if you have any interests, thank you!


Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.4-Trifluoromethylbenzyl chloride CAS:939-99-1 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.Metanilic acid Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.2-Bromoisobutyryl Bromide CAS:20769-85-1 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.Active pharmaceutical ingredients directly impact disease.